These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3919398)

  • 41. Characteristics of tumor necrosis factor production in rheumatoid arthritis.
    Yocum DE; Esparza L; Dubry S; Benjamin JB; Volz R; Scuderi P
    Cell Immunol; 1989 Aug; 122(1):131-45. PubMed ID: 2473844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synovial fluid crystals.
    Dieppe PA; Crocker PR; Corke CF; Doyle DV; Huskisson EC; Willoughby DA
    Q J Med; 1979 Oct; 48(192):533-53. PubMed ID: 231795
    [No Abstract]   [Full Text] [Related]  

  • 43. Synovial effusions containing cholesterol crystals report of 12 patients and review.
    Ettlinger RE; Hunder GG
    Mayo Clin Proc; 1979 Jun; 54(6):366-74. PubMed ID: 449407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of hydroxyapatite crystals in synovial fluid.
    Halverson PB; McCarty DJ
    Arthritis Rheum; 1979 Apr; 22(4):389-95. PubMed ID: 106859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Synovial zinc: relation to cartilage destruction and cell breakdown in rheumatoid arthritis].
    Ambanelli U; Ferraccioli GP; Serventi G; Bernardi P; Rocca E
    Boll Soc Ital Biol Sper; 1978 Jan; 54(1):99-104. PubMed ID: 737056
    [No Abstract]   [Full Text] [Related]  

  • 46. Hydroxyproline metabolism in serum, synovial fluid ans synovial membrane in joint diseases.
    Igari T; Tsuchizawa M; Obara K; Ono S
    Nihon Geka Hokan; 1968 Nov; 37(6):836-41. PubMed ID: 5751724
    [No Abstract]   [Full Text] [Related]  

  • 47. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
    Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
    J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum and synovial fluid osteocalcin in rheumatic diseases.
    Mattei JP; Ferrera V; Boutsen Y; Franceschi JP; Botti D; De Boissezon C; Kaphan G; Roux H
    Int J Clin Pharmacol Res; 1992; 12(3):103-7. PubMed ID: 1473875
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Serum complement and synovial complement. Respective variations in rheumatic pathology].
    Kourilsky O; Peltier AP; de Sèze S
    Nouv Presse Med; 1972 Jun; 1(26):1769-76. PubMed ID: 4538278
    [No Abstract]   [Full Text] [Related]  

  • 50. Incidence of autoantibodies against type I and type II interferons in a cohort of systemic lupus erythematosus patients in Slovakia.
    Slavikova M; Schmeisser H; Kontsekova E; Mateicka F; Borecky L; Kontsek P
    J Interferon Cytokine Res; 2003 Mar; 23(3):143-7. PubMed ID: 12716486
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protease inhibitors in rheumatoid synovial fluid. Analyses of electrophoretic homogeneity and protease inhibitory capacity.
    Ekerot L; Ohlsson K
    Rheumatol Int; 1982; 2(1):21-6. PubMed ID: 6184771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevated nerve growth factor levels in the synovial fluid of patients with inflammatory joint disease.
    Halliday DA; Zettler C; Rush RA; Scicchitano R; McNeil JD
    Neurochem Res; 1998 Jun; 23(6):919-22. PubMed ID: 9572681
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum activity that confers acid lability to alpha-interferon in systemic lupus erythematosus: its association with disease activity and its independence from circulating alpha-interferon.
    Yee AM; Yip YK; Fischer HD; Buyon JP
    Arthritis Rheum; 1990 Apr; 33(4):563-8. PubMed ID: 2328034
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Paired serum and synovial fluid values of alpha 2-macroglobulin and TIMP in rheumatoid arthritis.
    Cawston TE; McLaughlin P; Hazleman BL
    Br J Rheumatol; 1987 Oct; 26(5):354-8. PubMed ID: 2444303
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunoelectrophoretic assay for synovial fluid C3 with correction for synovial fluid globulin.
    Hasselbacher P
    Arthritis Rheum; 1979 Mar; 22(3):243-50. PubMed ID: 105740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Type I and II interferons commit to abnormal expression of chemokine receptor on B cells in patients with systemic lupus erythematosus.
    Yoshikawa M; Nakayamada S; Kubo S; Nawata A; Kitanaga Y; Iwata S; Sakata K; Ma X; Wang SP; Nakano K; Saito K; Tanaka Y
    Clin Immunol; 2019 Mar; 200():1-9. PubMed ID: 30576845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The role of IFN-gamma, IL-10, IL-12 and TRAIL in sera and synovium fluids from patients with rheumatoid arthritis].
    Xie YD; Jin L; Yu QW
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jun; 23(6):536-7. PubMed ID: 17553352
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interferon production from peripheral blood, synovial fluid, and synovial tissue lymphocytes in patients with rheumatoid arthritis and ankylosing spondylitis.
    Chou CT; Lee W; Chang ML; Lee CF; Kuo SY; Lin YM
    J Formos Med Assoc; 1990 Oct; 89(10):845-9. PubMed ID: 1706407
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Value of serum and synovial fluid activin A and inhibin A in some rheumatic diseases.
    El-Gendi SS; Moniem AE; Tawfik NM; Ashmawy MM; Mohammed OA; Mostafa AK; Zakhari MM; Herdan OM
    Int J Rheum Dis; 2010 Aug; 13(3):273-9. PubMed ID: 20704626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Electrophoretic and immunologic studies of joint punctate].
    Scheiffarth F; Götz H; Mohing W; Hecker FH
    Z Rheumaforsch; 1969; 28(3):125-38. PubMed ID: 5819566
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.